BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10954596)

  • 1. Loss of drug-stimulated topoisomerase II DNA breaks in living cells is different at two unrelated loci.
    Binaschi M; Borgnetto ME; Capranico G
    Nucleic Acids Res; 2000 Sep; 28(17):3289-93. PubMed ID: 10954596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
    Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin.
    Rowe TC; Wang JC; Liu LF
    Mol Cell Biol; 1986 Apr; 6(4):985-92. PubMed ID: 3023886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
    Borgnetto ME; Tinelli S; Carminati L; Capranico G
    J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
    Goodenow D; Emmanuel F; Berman C; Sahyouni M; Richardson C
    Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503144. PubMed ID: 32087851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II cleavage in chromatin.
    Udvardy A; Schedl P; Sander M; Hsieh TS
    J Mol Biol; 1986 Sep; 191(2):231-46. PubMed ID: 3027349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics.
    Käs E; Laemmli UK
    EMBO J; 1992 Feb; 11(2):705-16. PubMed ID: 1311255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.
    Sciascia N; Wu W; Zong D; Sun Y; Wong N; John S; Wangsa D; Ried T; Bunting SF; Pommier Y; Nussenzweig A
    Elife; 2020 Feb; 9():. PubMed ID: 32057297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot.
    Mirault ME; Boucher P; Tremblay A
    Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate.
    Zechiedrich EL; Christiansen K; Andersen AH; Westergaard O; Osheroff N
    Biochemistry; 1989 Jul; 28(15):6229-36. PubMed ID: 2551367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
    Udvardy A; Schedl P
    Mol Cell Biol; 1991 Oct; 11(10):4973-84. PubMed ID: 1656219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
    Atkin ND; Raimer HM; Wang YH
    Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity.
    Canela A; Maman Y; Huang SN; Wutz G; Tang W; Zagnoli-Vieira G; Callen E; Wong N; Day A; Peters JM; Caldecott KW; Pommier Y; Nussenzweig A
    Mol Cell; 2019 Jul; 75(2):252-266.e8. PubMed ID: 31202577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE; Rowe TC
    Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.
    Rao VA; Agama K; Holbeck S; Pommier Y
    Cancer Res; 2007 Oct; 67(20):9971-9. PubMed ID: 17942930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
    Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
    J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
    Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL
    Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.
    Gómez-Herreros F; Romero-Granados R; Zeng Z; Alvarez-Quilón A; Quintero C; Ju L; Umans L; Vermeire L; Huylebroeck D; Caldecott KW; Cortés-Ledesma F
    PLoS Genet; 2013; 9(3):e1003226. PubMed ID: 23505375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
    Wilstermann AM; Osheroff N
    Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.